Tag: CORO
Risks for Diabetes, CVD Up in Acute, Postacute COVID-19 Phases
However, from 13 to 52 weeks after COVID-19, no increase was seen for diabetes mellitus, cardiovascular disease
Increased Blood Viscosity Linked to Mortality in COVID-19
Hospitalized COVID-19 patients with increased estimated blood viscosity may have greater risk for in-hospital mortality
Fourth COVID-19 Vaccine Dose Safe for Immunocompromised
Local and systemic reactions reported less frequently after fourth dose versus dose 3 of primary vaccination series
U.S. Extends COVID-19 Public Health Emergency Another Three Months
Separate emergency declaration allows for the emergency use authorization of testing, treatments, and vaccines
Menstrual Bleeding Changes Reported After COVID-19 Vaccination
42 percent of those with regular menstrual cycles bled more heavily than usual after COVID-19 vaccination
WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
For nonsevere COVID-19, 11th version of living guideline recommends against fluvoxamine (except in context of clinical trial), colchicine
FDA Approves Emergency Use of Novavax COVID-19 Vaccine
Vaccine is given in two shots, three weeks apart
Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment
Finding from a nationwide study of 5,000 participants that continues to evaluate existing drugs to treat mild-to-moderate COVID-19
Impact of COVID-19 Pandemic on Infection Prevention Professionals Explored
65 percent of respondents reported burnout; more negative mental health impacts seen for frontline and practicing IPs
COVID-19 Incidence Not Increased With Corticosteroid Injections
Incidence of COVID-19 lower for adults receiving image-guided corticosteroid injections for pain management